It was a long 2-3 am for stroke calls, the hour dial back from daylight saving made it feel like a recurring nightmare 😶‍🌫️

Now we need to improve secondary prevention strategies for vulnerable patient groups like those with a history of ICH #ENRICH -AF PHRI.ca Population Health Research Institute 🇨🇦 and those with #breakthroughstrokes despite anticoagulation with our Schweizerischer Nationalfonds (SNF) funded ELAPSE Urs Martin Fischer Lorenz Räber, MD PhD

Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) – A systematic review

onlinelibrary.wiley.com/doi/full/10.11…

Thanks for highlighting the importance ti get additional data on IVT in patients on DOACS. We will just DO-IT Trial & Registry !@janpurrucker Thomas Meinel Teddy Wu Espen Saxhaug Kristoffersen Ashkan Shoamanesh Aristeidis Katsanos Luciana Catanese, MD Guri Hagberg Stroke Research Center Bern European Stroke Master Urs Martin Fischer

Excellent summary Medscape of SELECT 2 results presented at #ISC2024 . EVT benefit persisted at 1-year The Lancet , was maintained across wide spectrum of core & ASPECTS strata JAMA and in large core patients transferred for EVT JAMA Neurology

Ameer E. Hassan Michael Abraham Cerebrovascular & Neurointerventional Lab Shazam Hussain, MD Michael Chen, MD Vignan Yogendrakumar Nabeel Herial, MD, MPH, FAHA, FAAN Juan F. Arenillas Jenny P. Tsai MD BJ Hicks MD Dr. Nathan Manning Teddy Wu Natalia Perez-Ossa Pere Cardona Navi Sangha Fawaz Al-Mufti, MD, FSVIN Jordi Blasco Steven Warach Ammar Abdulrazzak, MD Nima Aghaebrahim Edgar A Samaniego P

SELECT 2 Endovascular thrombectomy functional outcomes and quality of life benefits persisted at 1-year follow-up. 28% EVT and 19% MM patients demonstrated at least 1-point improvement in mRS between 90-day and 1-year follow-up. #ISC2024 The Lancet thelancet.com/journals/lance…

@SELECT2trial, both directly presenting and transferred patients benefited from EVT, including those with low ASPECTS at referral hospitals. Longer transfer times and ASPECTS loss were associated with worse clinical outcomes. JAMA Neurology JAMA jamanetwork.com/journals/jaman…

Time matteres for IVT prior to thrombectomy! Great presentation of Johannes Kaesmacher from Stroke Research Center Bern at ISC and simultaneous publication in JAMA #alleyesoniris Fabiano Manon Kappelhof Kilian Treurniet Urs Martin Fischer

jamanetwork.com/journals/jama/…

SELECT 2 EVT improved outcomes across ASPECTS and core volumes strata, in those with/without mismatch. Composite core volumes correlated best with outcomes. CTP overestimation was infrequent(<1%). Reduced infarct growth with mTICI≥2b and mRS 0-2/0-3 jamanetwork.com/journals/jama/…

Viewpoint in JAMA Neurology on covert cerebrovascular disease by Thomas Meinel
JoannaWardlaw and David M Kent

jamanetwork.com/journals/jaman…

Professor Jose Biller and I will be moderating the Game of Strokes at #ISC2024 ! Join us on Thursday, Feb 08, at 4:45 PM (MST) in the Main Event Hall. Last year, Team Asia/Australia/South America won the trophy.
.
.
Who will emerge victorious this time? Don't miss out! 🏆🧠💥

📢An amazing group made this happens. It was all about teamwork, commitment and aiming for excellence !🙏

A helpful guide for providers managing patients with cervical artery dissection. Grateful for AHA Science for commissioning this statement and for all the support they provided. Also grateful for being part of this incredible co-author team. #stroke #CAD ahajournals.org/doi/10.1161/ST…

That was epic!!

Study findings suggest that pRESET offers a safe and effective option for flow restoration and disability reduction in patients with large vessel occlusion strokes. ja.ma/3S15GuY

Great international teamwork Teddy Wu Jan Purrucker Jan Scheitz 🧠⚡️❤️ Christian H Nolte Espen Saxhaug Kristoffersen UCL Stroke Research Johannes Kaesmacher Urs Martin Fischer Clinical Stroke and Imaging Research Shadi Yaghi Sven Poli and many others! Just DO-IT Trial & Registry, let’s get definite evidence Ashkan Shoamanesh Aristeidis Katsanos and Luciana

Seemant Chaturvedi JAMA Neurology European Stroke Org David Seiffge World Stroke Org 🙏🙏🙏
Rest assured, we will - together with all DO-IT Trial & Registry collaborators

David Seiffge Jan Purrucker Ashkan Shoamanesh Luciana Catanese, MD Aristeidis Katsanos Teddy Wu Urs Martin Fischer Johannes Kaesmacher

TNK approved for #stroke thrombolysis in Europe by EMA! 25mg vials available soon(ish)

ema.europa.eu/en/medicines/h…

Espen Saxhaug Kristoffersen David Seiffge DO-IT Trial & Registry 🙏 this is on behalf of you and all collaborators of this fantastic group! None of this would have been possible without your contributions...
Let's continue this success story!